Lipolysis: cellular mechanisms for lipid mobilization from fat stores

GF Grabner, H Xie, M Schweiger, R Zechner - Nature metabolism, 2021 - nature.com
The perception that intracellular lipolysis is a straightforward process that releases fatty
acids from fat stores in adipose tissue to generate energy has experienced major revisions …

Carboxylesterases in lipid metabolism: from mouse to human

J Lian, R Nelson, R Lehner - Protein & cell, 2018 - academic.oup.com
Mammalian carboxylesterases hydrolyze a wide range of xenobiotic and endogenous
compounds, including lipid esters. Physiological functions of carboxylesterases in lipid …

The role of human carboxylesterases in drug metabolism: have we overlooked their importance?

S Casey Laizure, V Herring, Z Hu… - … : The Journal of …, 2013 - Wiley Online Library
Carboxylesterases are a multigene family of mammalian enzymes widely distributed
throughout the body that catalyze the hydrolysis of esters, amides, thioesters, and …

[HTML][HTML] Silencing of lipid metabolism genes through IRE1α-mediated mRNA decay lowers plasma lipids in mice

JS So, KY Hur, M Tarrio, V Ruda, M Frank-Kamenetsky… - Cell metabolism, 2012 - cell.com
XBP1 is a key regulator of the unfolded protein response (UPR), which is involved in a wide
range of physiological and pathological processes. XBP1 ablation in liver causes profound …

A comprehensive review of UDP-glucuronosyltransferase and esterases for drug development

S Oda, T Fukami, T Yokoi, M Nakajima - Drug metabolism and …, 2015 - Elsevier
UDP-glucuronosyltransferase (UGT) and esterases are recognized as the most important
non-P450 enzymes because of their high contribution to drug metabolism. UGTs catalyze …

The pharmacological landscape and therapeutic potential of serine hydrolases

DA Bachovchin, BF Cravatt - Nature reviews Drug discovery, 2012 - nature.com
Serine hydrolases perform crucial roles in many biological processes, and several of these
enzymes are targets of approved drugs for indications such as type 2 diabetes, Alzheimer's …

The emerging role of human esterases

T Fukami, T Yokoi - Drug metabolism and pharmacokinetics, 2012 - jstage.jst.go.jp
In this review, novel aspects of the role of esterases, which contribute to the metabolism of
10% of therapeutic drugs, are described. Esterases hydrolyze the compounds that contain …

[HTML][HTML] Ethanol and its nonoxidative metabolites promote acute liver injury by inducing ER stress, adipocyte death, and lipolysis

SH Park, W Seo, MJ Xu, B Mackowiak, Y Lin… - Cellular and molecular …, 2023 - Elsevier
Background & Aims Binge drinking in patients with metabolic syndrome accelerates the
development of alcohol-associated liver disease. However, the underlying mechanisms …

Non-P450 drug-metabolizing enzymes: contribution to drug disposition, toxicity, and development

T Fukami, T Yokoi, M Nakajima - Annual Review of …, 2022 - annualreviews.org
Most clinically used drugs are metabolized in the body via oxidation, reduction, or hydrolysis
reactions, which are considered phase I reactions. Cytochrome P450 (P450) enzymes …

Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes

E Dominguez, A Galmozzi, JW Chang, KL Hsu… - Nature chemical …, 2014 - nature.com
Phenotypic screening is making a comeback in drug discovery as the maturation of chemical
proteomics methods has facilitated target identification for bioactive small molecules. A …